Presented by: Dr. Hanadi Kazkaz — Take an assiduous look at the complexities between Ehlers-Danlos syndromes (EDS) and other hypermobility syndrome (HMS) as we discuss clinical manifestations, the diagnostic workup, and what long term outcomes are for the hypermobility syndrome and Ehlers-Danlos syndromes patient.

Presented by: Linda Grinnell-Merrick, MS, NP-BC — In this session you will learn about how PsA impacts your pregnant patients and the latest ACR guidelines.

Presented by: Chris D’Adamo, PhD — In this session, we will take a look at an integrative approach to patient care, combining complementary and alternative treatments in addition to medical therapies commonly applied in rheumatology.

Presented by: Elizabeth Kirchner, DNP — Vasculitis can range from mild to life threatening symptoms, so it is important as providers to know where your patient falls on the spectrum. This session will cover a global overarching review of the disease, including detection, manifestations, and treatments.

Presented by: Eileen J. Lydon, ANP-BC — In this session, we will be walking through diagnosis to care for our patients with antiphospholipid syndrome (APS). We will be discussing pathophysiology, immunology, differential diagnosis, clinical presentation, and treatment of antiphospholipid syndrome.

Presented by: Carrie Beach, BSN, RN | Tiffany Westrich-Robertson (axSpA patient) — Though patients may not pay attention to codes that their healthcare providers jot down, nurses and advanced practice providers know just how important that clerical detail can be. In this session, we will break down what the recent ICD-10 classification of non-radiographic axial spondyloarthritis (nr-axSpA) means for you as a provider and the future treatment of non-radiographic axial spondyloarthritis.

Presented by: Nancy Eisenberger, MSN, APRN, FNP-C — Gout is the most common form of inflammatory arthritis seen in rheumatology patients, and the American College of Rheumatology (ACR) released in 2020 new Guidelines for the Management of Gout. In this learning session we will be exploring the these updated treatment guidelines as well as recent and pipeline treatments so we can best serve our patients with the most current research released.

Presented by: Christopher Palma, MD, Sc.M — It’s been nearly one year since COVID-19 was first identified as an infectious disease. Through the evolution and spread of the disease, we have learned a lot about what works and what we should avoid. In this session, we will talk about the most recent updates to treatment options for patients, particularly those with rheumatic diseases.

Presented by: Christopher Palma, MD, Sc.M — In this session, we will discuss the application of the fundamentals of immunology in patients with rheumatoid arthritis.

Presented by: Jacqueline M. Fritz RN, MSN, RN-BC — This session will focus on the common findings, challenges, and targets of therapy including the use of disease modifying osteoarthritis drugs (DMOADS) in patients with osteoarthritic knees.

Presented by: Monica Richey, NP — Transfer of care from pediatrics to adults can be difficult for patients, especially for patients diagnosed with lupus, a disease with a high rate of comorbidity. In this session, we will address comorbid manifestations in lupus, and how to best prepare our patients for their transition to adult providers.